William W.
Chin is currently the Co-Chairman of Project SUCCESS, Director at ImClone LLC, Director at Agency for Science, Technology & Research, Director at Regenacy Pharmaceuticals LLC, Non-Executive Director at Deck Therapeutics, Inc., Director at Alopexx, Inc., and Board Member at Agency For Science Technology & Research Ventures.
He previously held positions such as Executive Medical Director at Healthcare Partners Medical Group, SVP-Discovery Research & Clinical Investigation at Eli Lilly & Co., Chief-Genetics Division at The Brigham & Women's Hospital, Investigator at Howard Hughes Medical Institute, Chief Medical Officer & Executive VP-Science at Pharmaceutical Research & Manufacturers of America, Member-Governing Board at Indianapolis Museum of Art, President at Interurban Clinical Club, and President at American Thyroid Association.
He also served as the Executive Dean & Professor at Harvard Medical School from 2013 to 2018 and as a Professor at California State University-Los Angeles.
Chin received his undergraduate degree from Columbia College (California) and his doctorate from State University of New York at Buffalo and Harvard Medical School.